SCHEMBL153253

SCHEMBL153253

COC1CCC(N)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3539502 1.00
SCHEMBL153252 1.00
Hydrochloric Acid SCHEMBL154419 0.97 DPP4 (0.31)
Hydrochloric Acid SCHEMBL150794 0.97 DPP4 (0.31)
Hydrochloric Acid SCHEMBL150793 0.97 DPP4 (0.31)
Hydrochloric Acid SCHEMBL16448116 0.97 DPP4 (0.31)
Hydrochloric Acid SCHEMBL16448114 0.97 DPP4 (0.31)
SCHEMBL10052671 0.92
SCHEMBL6272620 0.89 DPP4 (0.32)
SCHEMBL30363451 0.89 DPP4 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 616 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114031974-A Ink for ink jet printing and electroluminescent device 广东聚华印刷显示技术有限公司 2022-02-11 CN claimed
CN-109748903-B Preparation method of pyrifazimine 北京协和制药二厂 2021-08-10 CN claimed
CN-109748903-A The aplanatic preparation method of pyrrole method 北京协和制药二厂 2019-05-14 CN claimed
CN-109503591-A Pharmaceutical composition, its solid form and their purposes of dihydro pyrazine and pyrazine compound 西格诺药品有限公司 2019-03-22 CN claimed
CN-107474051-A Pharmaceutical composition, its solid form and their purposes of dihydro pyrazine and pyrazine compound 西格诺药品有限公司 2017-12-15 CN claimed
CN-103703011-B Platinum compounds with leaving group of hydroxy acid derivative containing amino or alkylamino, and preparation method and application thereof 北京市丰硕维康技术开发有限责任公司 2016-06-22 CN claimed
CN-105407892-A Pharmaceutical compositions of 7- (6- (2-hydroxypropan-2-yl) pyridin-3-yl) -1- ((trans) -4-methoxycyclohexyl) -3, 4-dihydropyrazino [2,3-B ] pyrazin-2 (1H) -one, solid forms thereof, and methods of their use SIGNAL PHARM LLC 2016-03-16 CN claimed
EP-1689702-B1 ORGANIC COMPOUNDS NOVARTIS AG (CH) 2013-01-30 EP claimed
EP-1121372-B1 ADENINE DERIVATIVES PFIZER LTD (GB) 2006-06-28 EP claimed
US-6326359-B1 PURINE DERIVATIVES PFIZER INC 2001-12-04 US claimed
EP-1121372-A1 ADENINE DERIVATIVES Pfizer Limited (GB) 2001-08-08 EP claimed
WO-2000023457-A1 ADENINE DERIVATIVES PFIZER LIMITED (GB) 2000-04-27 WO claimed
US-20260138990-A1 TRICYCLIC FUSED IMIDAZOLE COMPOUNDS AS CD38 MODULATORS AND USES THEREOF AEOVIAN PHARMACEUTICALS INC (US) 2026-05-21 US disclosed
EP-4727944-A1 [1,2,4]-TRIAZOLO[4,3-B]PYRIDAZINE DERIVATIVES USEFUL AS A MEDICAMENT Perha Pharmaceuticals (FR) 2026-04-22 EP disclosed
US-12606561-B2 Substituted pyrazolo[1,5-a][1,3,5]triazines as CDK inhibitors QURIENT CO., LTD. (KR) 2026-04-21 US disclosed
EP-4724430-A1 CONDENSED AZINES AS INHIBITORS OF CYCLIC ADP RIBOSE HYDROLASE Flagship Pioneering Innovations VI, LLC (US) 2026-04-15 EP disclosed
EP-0296748-A1 Cycloalkylamides of (8Beta)-1-alkyl-6-(substituted) ergolines ELI LILLY AND COMPANY (US) 1988-12-28 EP disclosed
US-4315940-A Antidiabetic 1-piperidine-sulfonylureas HOECHST AKTIENGESELLSCHAFT (DE) 1982-02-16 US disclosed
EP-0030650-A1 1-Piperidinesulfonyl ureas, processes for their preparation, pharmaceutical compositions based on these compounds and their use HOECHST AKTIENGESELLSCHAFT (DE) 1981-06-24 EP disclosed
US-3995059-A CHOLESTEROL LOWERING AGENTS SUMITOMO CHEMICAL COMPANY, LIMITED (JA) 1976-11-30 US disclosed